arrow_back Trending Legislation
Share share

Medicare payment changes to boost access to innovative nuclear diagnostics.

This law changes Medicare payment rules to ensure hospitals receive separate reimbursement for expensive, innovative drugs used in nuclear diagnostics (radiopharmaceuticals). The goal is to guarantee that Medicare beneficiaries have easier access to the latest disease detection methods. These changes take effect on January 1, 2024.
Key points
Medicare will pay hospitals separately for expensive diagnostic drugs (radiopharmaceuticals) if their cost exceeds $500 per day (this threshold will increase annually).
This change removes a financial barrier for hospitals, aiming to improve Medicare beneficiaries' access to modern and innovative diagnostic tests.
The new payment rules will not affect the amount of out-of-pocket costs (copayments) paid by patients.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Facilitating Innovative Nuclear Diagnostics Act of 2023
Print number: S 1544
Sponsor: Sen. Blackburn, Marsha [R-TN]
Process start date: 2023-05-10